Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, November 1998, p. 3000-3001, Vol. 42, No. 11
Department of Biomedical Sciences, Clinical
Microbiology Laboratory, "G. D'Annunzio" University, I-66100
Chieti, Italy
Received 16 March 1998/Returned for modification 2 June
1998/Accepted 8 August 1998
The susceptibilities of 87 periodontitis-associated strains of
Actinobacillus actinomycetemcomitans to clarithromycin and erythromycin were determined by standard methodology recommended for
Haemophilus influenzae. For clarithromycin the MIC at which 90% of the isolates were inhibited was
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Bacteriostatic and Bactericidal In Vitro Activities of
Clarithromycin and Erythromycin against Periodontopathic
Actinobacillus actinomycetemcomitans
2.0 µg/ml and the minimal bactericidal concentration at which 90% of the strains were killed was
4.0 µg/ml, suggesting that it would be a candidate for therapeutic trials in patients with periodontitis.
*
Corresponding author. Mailing address: Dipartimento di
Scienze Biomediche, Laboratorio di Microbiologia Clinica,
Università "G. d'Annunzio," Via dei Vestini, 31, I-66100
Chieti, Italy. Phone: (39) 871-3555283. Fax: (39) 871-3555282. E-mail:
r.piccolomini{at}dsb.unich.it.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»